Israel Chemicals Ltd. (ICL), Tel Aviv, reported first-quarter net income attributable to shareholders of $139 million ($0.11 per diluted share) on sales of $1.42 billion, sharply down from the year-ago $928 million ($0.73 per diluted share) and $1.40 billion, respectively. However, net income adjusted for non-recurring costs was $150 million ($0.12 per diluted share), versus the year-earlier $106 million. Potash sales volumes (including internal sales) were down 8 percent, at 1.014 million mt from 1.106 million mt.